| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000034397 |
| Receipt No. | R000038957 |
| Official scientific title of the study | A multicenter, cluster randomized controlled trial to investigate the effectiveness of the treatment guideline for major depressive disorder in Japan |
| Date of disclosure of the study information | 2019/01/01 |
| Last modified on | 2018/09/27 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A multicenter, cluster randomized controlled trial to investigate the effectiveness of the treatment guideline for major depressive disorder in Japan | |
| Title of the study (Brief title) | A multicenter, cluster randomized controlled trial to investigate the effectiveness of the treatment guideline for major depressive disorder in Japan | |
| Region |
|
|
| Condition | ||
| Condition | Major depressive disorder | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study aims to examine the effectiveness of an intervention program composed of two components (i.e., lectures and practical applications) on psychiatrists. The lectures cover the guideline-recommended treatments for depression. The practical applications involve increasing patient participation in shared decision making. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The primary outcome is the shared decision making scores at baseline, 4 weeks, and 12 weeks after enrollment in the study. |
| Key secondary outcomes | 1) Client Satisfaction Questionnaire (CSQ-8-J) scores at baseline, 4 weeks, and 12 weeks
2) EuroQol 5 Dimension (EQ-5D) scores at baseline, 4 weeks, and 12 weeks 3) Trust in Physician Scale (TPS) scores at baseline, 4 weeks, and 12 weeks 4) Quick Inventory of Depressive Symptomatology (QIDS-J) scores at baseline, 4 weeks, and 12 weeks |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is considered as a block. |
| Blocking | YES |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | The intervention will be carried out in one-day workshop. The training program consists of lectures (treatment guideline for major depressive disorder) and group education (social function, QOL, and shared decision making).
|
|
| Interventions/Control_2 | The control group will be under the "treatment as usual" (TAU) condition without the intervention. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who meet the criteria for major depressive disorder according to DSM-5 and who are able to provide written informed consent. | |||
| Key exclusion criteria | 1) Severe depressive symptoms that require hospitalization
2) Having urgent suicidal ideation 3) Severe physical illness 4) Having dementia 5) Ongoing alcohol or substance abuse 6) Disturbance of consciousness |
|||
| Target sample size | 204 | |||
| Research contact person | |
| Name of lead principal investigator | Koichiro Watanabe |
| Organization | Kyorin University |
| Division name | Department of Neuropsychiatry, School of Medicine |
| Address | 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan |
| TEL | 0422-47-5511 |
| koichiro@tke.att.ne.jp | |
| Public contact | |
| Name of contact person | Yoshikazu Takaesu |
| Organization | Kyorin University |
| Division name | Department of Neuropsychiatry, School of Medicine |
| Address | 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan |
| TEL | 0422-47-5511 |
| Homepage URL | |
| takaesu@ks.kyorin-u.ac.jp | |
| Sponsor | |
| Institute | Japan Agency for Medical Research and Development |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038957 |